Pharmacy Review vs Home Medicines Review (HMR)

Both review types exist, but they serve different purposes. Understand which approach benefits your insurance claims most.

Published 3 April 2026

Understanding the Two Review Approaches

Your organisation likely encounters both pharmacy reviews and Home Medicines Reviews (HMRs). While these terms sometimes overlap, they describe distinct service models with different purposes, settings, and outcomes for insurance claims.

Pharmacy reviews conducted for insurance purposes differ fundamentally from HMRs funded through the Pharmaceutical Benefits Scheme for community-dwelling older adults. Understanding these differences helps you choose the right approach for your claims.

What Is Home Medicines Review (HMR)?

HMR is a government-funded service under the Pharmaceutical Benefits Scheme. A community pharmacist visits your claimant's home (or aged care facility) to conduct comprehensive medication review. The review emphasises home environment factors, medication management capacity, and practical implementation challenges.

HMR Funding and Access

HMRs are funded through Medicare for eligible patients aged 75 years and over, or aged 65 and over with multiple comorbidities. Your claimant meeting these criteria may access HMR through their general practitioner referral at no cost to the claimant.

HMR Process

The community pharmacist conducting HMR interviews your claimant, observes their home environment and medication storage, assesses adherence capacity, identifies medication problems, and prepares a report for the referring doctor. The focus emphasises practical medication management in the home setting.

HMR Report Structure

HMR reports typically document medication list reconciliation, identification of medication-related problems, practical recommendations for improved management, and communication with the general practitioner who requested the review.

What Is Insurance Pharmacy Review?

Insurance pharmacy review is conducted specifically to assess medication risk and optimisation for insurance claims. Your pharmacy reviewer is engaged by the insurer to evaluate your claimant's medications through a claims management lens.

Insurance Review Focus

Insurance pharmacy reviews prioritise claim-specific concerns: medication appropriateness relative to injury and recovery, medication-related risks affecting claim duration, cost-effectiveness of medication regimens, and deprescribing opportunities. The reviewer acts as an agent for the insurer.

Insurance Review Scope

Your pharmacy reviewer has full access to claims data, medical records, and investigation reports. This contextual information allows assessment of medication regimen relative to your claimant's injury and recovery trajectory.

Insurance Review Recommendations

Insurance pharmacy recommendations focus on claim outcomes: optimising medication for faster recovery, identifying medication barriers to rehabilitation, preventing medication-related adverse events, and reducing medication-related costs.

Key Differences for Your Claims

Several critical differences affect which review type benefits your claims:

When HMR Is Appropriate for Your Claims

HMR benefits certain claimant situations:

Elderly Claimant in Community Setting

Your claimant aged 75 or over or aged 65 with significant comorbidities benefits from HMR. The home visit allows assessment of real-world medication management capacity, environment assessment, and practical problem-solving.

Medication Adherence Uncertainty

If your claimant's medication adherence is questionable, HMR's home assessment may identify barriers to adherence. Observing how your claimant manages medications at home provides insights that pharmacy office-based review cannot capture.

Aged Care Resident

Your claimant in aged care facility benefits from HMR conducted in that setting. The pharmacist can directly assess care facility medication management systems and identify system-level problems affecting your claimant's medications.

Community Pharmacy Relationship Strong

When your claimant has established relationship with their community pharmacist, HMR referral through the existing GP leverages that relationship and existing medication knowledge.

When Insurance Pharmacy Review Is Better for Your Claims

Insurance pharmacy review is superior for most insurance claim scenarios:

Claims-Specific Risk Assessment Needed

When your concern is whether your claimant's medications support recovery and prevent complications, insurance pharmacy review provides claims-specific expertise. Your reviewer understands medication risks in injury recovery context.

Complex Medication Regimen

Your claimant on multiple medications with complex interactions benefits from specialist insurance pharmacist with claims management expertise. Insurance pharmacists are trained specifically in medication optimisation for claims outcomes.

Urgent Assessment Required

HMR requires GP referral and waits for home pharmacist availability. Insurance review can be initiated immediately by your claims team, providing rapid assessment when urgent decisions are needed.

Access Issues for Your Claimant

Your claimant unable to access community pharmacy, resistant to home visits, or residing outside standard HMR access areas benefits from insurance pharmacy review which requires no claimant participation.

Deprescribing Strategy Needed

When your medication concern is systematic deprescribing to improve recovery, insurance pharmacists have specific deprescribing expertise. Most community HMR pharmacists focus on medication management rather than deprescribing strategy.

Prescriber Communication Required

Insurance pharmacists typically communicate directly with treating doctors and specialists. HMRs report primarily to the referring GP. Insurance review ensures your medication recommendations reach all relevant prescribers.

Can Your Claimant Benefit From Both?

In some situations, both review types have value:

Scenario: Your elderly claimant (75+) with complex injury and substantial medication regimen needs comprehensive assessment.

Approach: Insurance pharmacy review provides claims-specific risk assessment and deprescribing strategy. HMR provides home environment assessment and community pharmacy engagement. Sequencing them appropriately allows both benefits.

Timing: Insurance review first identifies medication optimisation strategy. HMR later assesses home implementation of that strategy and addresses practical adherence barriers.

Quality and Outcomes Differences

The review types differ in outcomes they achieve:

HMR Outcomes

HMRs typically improve medication adherence and identify practical home management problems. Your claimant receiving HMR often shows improved medication taking and better understanding of their medication regimen.

Insurance Pharmacy Review Outcomes

Insurance reviews produce medication optimisation benefiting claim duration and recovery. Your claimant receiving insurance pharmacy review typically shows reduced medication costs, faster recovery, and shorter claim duration.

Cost Considerations

Funding sources differ significantly:

HMR: No cost to eligible claimant; funded through Pharmaceutical Benefits Scheme. Your organisation incurs no direct cost. However, your organisation doesn't control timing or reviewer selection.

Insurance Pharmacy Review: Direct cost to insurer organisation. However, your organisation controls timing, reviewer selection, and report scope. Return on investment typically exceeds cost through improved claim outcomes.

Your Decision Framework

Consider these factors when choosing review type:

Best Practice: Integrated Approach

Your most effective claims strategy may integrate both review types:

• Insurance pharmacy review provides claims optimisation strategy
• HMR ensures community pharmacy engagement and home implementation
• Insurance pharmacist and community pharmacist communicate regarding recommendations
• Your claimant benefits from both specialist claims expertise and community pharmacy continuity